Published in

Taylor and Francis Group, Expert Opinion on Pharmacotherapy, 6(21), p. 679-686, 2020

DOI: 10.1080/14656566.2020.1724283

Links

Tools

Export citation

Search in Google Scholar

ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO